SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark A. Stang who wrote (11048)7/9/1998 9:51:00 PM
From: EyeDrMike  Read Replies (2) of 23519
 
<< VVUS has $16M in inventory, up from $9M last quarter. Based on 2-Q sales (w/no increase), that's a 3-month backlog. I noted my concern about inventory in a posting yesterday.>>

VVUS is contractually bound to purchase raw materials, and they get it cheaper on higher volume. I think this is what "inventory" they are referring to. Finished product is being shipped as it is produced, ALL
of it., None is being warehoused.

Shelf life on MUSE 18 months.

The reported EPS today should surprise no one. The 3 Q will make or break this company. And anyone who's been buying this stock at six, and you've had chances, has had ample opportunity to make money.

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext